Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye

Shareholder Information

Oxurion is listed on Euronext Brussels under the symbol OXUR.

As of 31 December 2019, Oxurion has a total number of 38,291,950 outstanding shares and a total number of 1,301,000 warrants, of which 697,800 are accepted unexercised, 417,000 are offered, but not yet accepted and 186,200 are to be assigned.

KBC Bank is acting as the paying agent. The paying agent will not charge shareholders with respect to payments of dividends, the exercise of subscription rights and other events concerning Oxurion shares. Shareholders should inform themselves about the amounts that other financial intermediaries may charge in connection with paying agency services.

View Shareholders History of Capital


Annual Shareholders Meeting 2020
  • Convocation of annual shareholders' meeting on May 5, 2020 - view document
  • Proxy form for the annual shareholders' meeting of May 5, 2020 - view document
  • Shareholders' rights for AGM of 5 May 2020 - view document
  • Statutory accounts for the financial year 2019 - view document
  • Annual report - financial information 2019 - view document
  • Annual Report of the Board of Directors on the consolidated financial statements for the FY 2019 - view document
  • Annual Report of the Board of Directors on the statutory accounts for the FY 2019 - view document
  • Auditor's report in relation to the consolidated accounts for the financial year 2019 - view document
  • Auditor's report in relation to the statutory accounts for the financial year 2019 - view document

Archive